URO-1
Latest round
- Series A
Last raised
- Sep 2017
Total raised
- $1.1M
Investors
- 1
About URO-1
Founded in 2017 and based in North Carolina, US, URO-1 Inc. operates as a medical device manufacturer providing solutions for office-based urology and urogynecology procedures. As of 2024, the company is headed by its CEO Ted Belleza. The company offers medical devices for the diagnosis and treatment of urologic disorders. The firm products are used in prostate biopsy for men as well as for the treatment of overactive bladder (OAB) in women. The firm product range includes SUREcore Prostate Biopsy Needle, coreCARE Specimen Retrieval Kit, and intravesical injection.
Who invested in URO-1
1 investor across 1 round
See all investors in URO-1
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 6, 2017
Amount
$1.1M
Investors
Questions about URO-1
Who invested in URO-1?
URO-1 has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has URO-1 raised?
URO-1 has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did URO-1 last raise money?
URO-1's most recent round on record is a Series A, in Sep 2017.
What does URO-1 do?
Founded in 2017 and based in North Carolina, US, URO-1 Inc.
Where is URO-1 headquartered?
URO-1 is headquartered in Winston-Salem, US.
Which VCs invest in companies like URO-1?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at URO-1's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like URO-1? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.